Find Remetinostat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 946150-57-8, Remetinostat [usan], Shp-141, Methylparaben suberohydroxamic acid phenyl ester, Methyl 4-((8-(hydroxyamino)-8-oxooctanoyl)oxy)benzoate, Nsc-748492
Molecular Formula
C16H21NO6
Molecular Weight
323.34  g/mol
InChI Key
XDZAHHULFQIBFE-UHFFFAOYSA-N
FDA UNII
37NT056AT4

Remetinostat
Remetinostat is a topical formulation containing the histone deacetylase (HDAC) inhibitor with potential antineoplastic activity. Upon cutaneous administration, SHP-141 selectively binds to and inhibits HDAC, resulting in an accumulation of highly acetylated histones in the skin (dermis and epidermis), the induction of chromatin remodeling, and the selective transcription of tumor suppressor genes. These events may result in the inhibition of tumor cell division and the induction of tumor cell apoptosis. HDACs, upregulated in many tumor cell types, are a family of metalloenzymes responsible for the deacetylation of chromatin histone proteins. Topical administration of SHP-141 allows for high concentrations of this agent locally while minimizing systemic toxicity.
1 2D Structure

Remetinostat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
methyl 4-[8-(hydroxyamino)-8-oxooctanoyl]oxybenzoate
2.1.2 InChI
InChI=1S/C16H21NO6/c1-22-16(20)12-8-10-13(11-9-12)23-15(19)7-5-3-2-4-6-14(18)17-21/h8-11,21H,2-7H2,1H3,(H,17,18)
2.1.3 InChI Key
XDZAHHULFQIBFE-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COC(=O)C1=CC=C(C=C1)OC(=O)CCCCCCC(=O)NO
2.2 Other Identifiers
2.2.1 UNII
37NT056AT4
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Methyl 4-(8-(hydroxyamino)-8-oxooctanoyl)oxybenzoate

2.3.2 Depositor-Supplied Synonyms

1. 946150-57-8

2. Remetinostat [usan]

3. Shp-141

4. Methylparaben Suberohydroxamic Acid Phenyl Ester

5. Methyl 4-((8-(hydroxyamino)-8-oxooctanoyl)oxy)benzoate

6. Nsc-748492

7. 37nt056at4

8. Benzoic Acid, 4-((8-(hydroxyamino)-1,8-dioxooctyl)oxy)-, Methyl Ester

9. Methyl 4-{[8-(hydroxyamino)-8-oxooctanoyl]oxy}benzoate

10. Unii-37nt056at4

11. Remetinostat (usan/inn)

12. Remetinostat [inn]

13. Remetinostat [who-dd]

14. Methyl 4-[8-(hydroxyamino)-8-oxooctanoyl]oxybenzoate

15. Chembl3707219

16. Schembl12682510

17. Dtxsid20647779

18. Shp-141shp-141

19. Bcp30561

20. Ex-a3219

21. Wmb15057

22. Nsc748492

23. Akos037649302

24. Db14869

25. Nsc 748492

26. Bs-17956

27. Db-088836

28. Hy-100365

29. Cs-0018698

30. D10977

31. Shp-141; Shp 141; Shp141; Shape

32. Q27256692

33. Benzoic Acid,8-dioxooctyl]oxy]-, Methyl Ester (mp-shape)

2.4 Create Date
2008-08-25
3 Chemical and Physical Properties
Molecular Weight 323.34 g/mol
Molecular Formula C16H21NO6
XLogP32
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count11
Exact Mass323.13688739 g/mol
Monoisotopic Mass323.13688739 g/mol
Topological Polar Surface Area102 Ų
Heavy Atom Count23
Formal Charge0
Complexity390
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty